Search

Your search keyword '"Djanani, A."' showing total 12 results
Start Over Author "Djanani, A." Journal annals of oncology
12 results on '"Djanani, A."'

1. 1552P Patterns of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of gemcitabine/nab-paclitxel or FOLFIRINOX

Author

Schwarzenbacher, E., primary, Moik, F., additional, Posch, F., additional, Horvath, L., additional, Gantschnigg, A., additional, Renneberg, F., additional, Barth, D., additional, Stotz, M., additional, Schaberl-Moser, R., additional, Pichler, M., additional, Ay, C., additional, Stöger, H., additional, Greil, R., additional, Djanani, A., additional, Gerger, A., additional, Schlick, K., additional, and Riedl, J.M., additional

Published
2020
Full Text
View/download PDF

2. 1530P Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis

Author

Riedl, J.M., primary, Posch, F., additional, Horvath, L., additional, Gantschnigg, A., additional, Renneberg, F., additional, Schwarzenbacher, E., additional, Moik, F., additional, Barth, D., additional, Stotz, M., additional, Schaberl-Moser, R., additional, Pichler, M., additional, Stöger, H., additional, Greil, R., additional, Djanani, A., additional, Schlick, K., additional, and Gerger, A., additional

Published
2020
Full Text
View/download PDF

4. 1552P Patterns of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of gemcitabine/nab-paclitxel or FOLFIRINOX

Author

Michael Stotz, Florian Moik, Herbert Stöger, Konstantin Schlick, Jakob M. Riedl, Lisa G. Horvath, Martin Pichler, Antonia Gantschnigg, Armin Gerger, Cihan Ay, Angela Djanani, Esther Schwarzenbacher, Richard Greil, Felix Renneberg, Renate Schaberl-Moser, Florian Posch, and Dominik A. Barth

Subjects
Oncology, medicine.medical_specialty, FOLFIRINOX, business.industry, Hematology, medicine.disease, Gemcitabine, Internal medicine, Pancreatic cancer, medicine, In patient, First line chemotherapy, business, medicine.drug
Published
2020
Full Text
View/download PDF

5. 1530P Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis

Author

Jakob M. Riedl, Michael Stotz, Esther Schwarzenbacher, Angela Djanani, Herbert Stöger, Richard Greil, Konstantin Schlick, Renate Schaberl-Moser, Armin Gerger, Dominik A. Barth, Martin Pichler, Felix Renneberg, Lisa G. Horvath, Florian Moik, Florian Posch, and Antonia Gantschnigg

Subjects
Oncology, medicine.medical_specialty, FOLFIRINOX, business.industry, Hematology, medicine.disease, Gemcitabine, First line treatment, Pancreatic cancer, Internal medicine, Propensity score matching, medicine, business, medicine.drug, Nab-paclitaxel
Published
2020
Full Text
View/download PDF

7. The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study

Author

Riedl, J., primary, Posch, F., additional, Prager, G., additional, Eisterer, W., additional, Öhler, L., additional, Thamer, S., additional, Wilthoner, K., additional, Petzer, A., additional, Pichler, P., additional, Hubmann, E., additional, Winder, T., additional, Burgstaller, S., additional, Korger, M., additional, Andel, J., additional, Greil, R., additional, Pecherstorfer, M., additional, Philipp-Abbrederis, K., additional, Djanani, A., additional, Gruenberger, B., additional, Längle, F., additional, Wöll, E., additional, and Gerger, A., additional

Published
2019
Full Text
View/download PDF

8. Austrian real world data in elderly and younger metastatic pancreatic cancer patients: Interim results of a multicenter non-interventional study with nab-paclitaxel/gemcitabine

Author

A. Petzer, Birgit Gruenberger, E. Hubmann, Friedrich Längle, Johannes Andel, Angela Djanani, Thomas Winder, Armin Gerger, H. Neumann, Brigitte Mlineritsch, P. Pichler, M. Pecherstorfer, Kathrin Philipp-Abbrederis, T. Sliwa, Wolfgang Eisterer, M. Korger, K. Wilthoner, Sonja Burgstaller, Ewald Wöll, Gerald W. Prager, and Leopold Öhler

Subjects
Oncology, medicine.medical_specialty, business.industry, Hematology, Gemcitabine, Interim, Internal medicine, Non interventional, Metastatic pancreatic cancer, medicine, business, Real world data, medicine.drug, Nab-paclitaxel
Published
2018
Full Text
View/download PDF

9. The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study

Author

Gerald W. Prager, E. Hubmann, S. Thamer, Sonja Burgstaller, Friedrich Längle, Johannes Andel, Jakob M. Riedl, Wolfgang Eisterer, M. Pecherstorfer, P. Pichler, Ewald Wöll, Leopold Öhler, K. Wilthoner, Kathrin Philipp-Abbrederis, Birgit Gruenberger, M. Korger, A. Petzer, Richard Greil, Florian Posch, Thomas Winder, Angela Djanani, and Armin Gerger

Subjects
Oncology, medicine.medical_specialty, business.industry, First line, Hematology, medicine.disease, Gemcitabine, Pancreatic cancer, Internal medicine, Post-hoc analysis, Non interventional, medicine, business, Nab-paclitaxel, medicine.drug
Published
2019
Full Text
View/download PDF

10. Austrian real world data in elderly and younger metastatic pancreatic cancer patients: Interim results of a multicenter non-interventional study with nab-paclitaxel/gemcitabine

Author

Eisterer, W., primary, Gerger, A., additional, Öhler, L., additional, Mlineritsch, B., additional, Sliwa, T., additional, Wilthoner, K., additional, Petzer, A., additional, Pichler, P., additional, Hubmann, E., additional, Winder, T., additional, Burgstaller, S., additional, Korger, M., additional, Andel, J., additional, Wöll, E., additional, Neumann, H., additional, Pecherstorfer, M., additional, Philipp-Abbrederis, K., additional, Djanani, A., additional, Gruenberger, B., additional, Längle, F., additional, and Prager, G., additional

Published
2018
Full Text
View/download PDF

11. P-286 - The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study

Author

Riedl, J., Posch, F., Prager, G., Eisterer, W., Öhler, L., Thamer, S., Wilthoner, K., Petzer, A., Pichler, P., Hubmann, E., Winder, T., Burgstaller, S., Korger, M., Andel, J., Greil, R., Pecherstorfer, M., Philipp-Abbrederis, K., Djanani, A., Gruenberger, B., Längle, F., Wöll, E., and Gerger, A.

Published
2019
Full Text
View/download PDF

12. P-034 - Austrian real world data in elderly and younger metastatic pancreatic cancer patients: Interim results of a multicenter non-interventional study with nab-paclitaxel/gemcitabine

Author

Eisterer, W., Gerger, A., Öhler, L., Mlineritsch, B., Sliwa, T., Wilthoner, K., Petzer, A., Pichler, P., Hubmann, E., Winder, T., Burgstaller, S., Korger, M., Andel, J., Wöll, E., Neumann, H., Pecherstorfer, M., Philipp-Abbrederis, K., Djanani, A., Gruenberger, B., Längle, F., and Prager, G.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results